Ken W. Marshall - 04 Nov 2022 Form 4 Insider Report for Aquestive Therapeutics, Inc. (AQST)

Role
SVP, Chief Commercial Officer
Signature
/s/ Lori Braender, as Attorney-In-Fact
Issuer symbol
AQST
Transactions as of
04 Nov 2022
Transactions value $
$0
Form type
4
Filing time
08 Nov 2022, 09:23:09 UTC
Previous filing
14 Mar 2022
Next filing
09 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AQST Non-Qualified Stock Option (right to buy) Award $0 +40,000 $0 40,000 04 Nov 2022 Common Stock 40,000 $0.875 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.